Novak Rodger 4
4 · CRISPR Therapeutics AG · Filed Jul 1, 2021
Insider Transaction Report
Form 4
Novak Rodger
DirectorChief Executive Officer
Transactions
- Sale
Common Shares
2021-06-30$165.00/sh−25,000$4,125,000→ 573,007 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.